PFBT
ZYME icon

Parkside Financial Bank & Trust’s Zymeworks ZYME Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-156
Closed -$1.86K – 3016
2025
Q1 		$1.86K Buy
+156
New +$2.13K ﹤0.01% 1911

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Parkside Financial Bank & Trust's ZYME Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 156 shares — an estimated $1.86K sold.

Parkside Financial Bank & Trust first reported a position in ZYME in Q1 2025 and held it in 1 quarter. The position peaked at $1.86K in Q1 2025. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 156 Zymeworks shares in Q2 2025, an estimated $1.86K.
  • Parkside Financial Bank & Trust first reported a position in Zymeworks in Q1 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Zymeworks position peaked at $1.86K in Q1 2025.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.